Condition: Diabetic Foot Ulcer · Sponsor: Piomic Medical
The purpose of this clinical trial is to evaluate the safety and effectiveness of the treatment with the COMS One device in subjects with refractory diabetic foot ulcers (DFUs). The prospective randomized, double-blinded, sham-controlled trial is designed to demonstrate superiority of wound closure of the COMS One device to a sham-control device through 24 weeks post-application, when each is administered in conjunction with standard of care (SOC) in the treatment of DFUs.
This description comes directly from the study's public registry record.
Rejelle Williams · +41 44 244 19 78 · williams@piomic.com
Bernard Laurel · +1-855-574-6642 · laurel@piomic.com
Always discuss trial participation with your own doctor first.
| Titan Clinical Research | Mesa, Arizona, United States | Recruiting |
| Southern Arizona VA Health Care System | Tucson, Arizona, United States | Recruiting |
| Center for Clinical Research Inc. | Castro Valley, California, United States | Recruiting |
| VA Central California Healthcare | Fresno, California, United States | Recruiting |
| Limb Preservation Platform, Inc. | Fresno, California, United States | Recruiting |
| Angel City Research, Inc. | Los Angeles, California, United States | Recruiting |
| UCLA Ronald Regan - Department of Surgery | Los Angeles, California, United States | Recruiting |
| Center for Clinical Research Inc. | San Francisco, California, United States | Recruiting |
| Center for Clinical Research Inc. | San Francisco, California, United States | Recruiting |
| ILD Research Center | Vista, California, United States | Recruiting |
| Bay Pines VA Healthcare System | Bay Pines, Florida, United States | Recruiting |
| MCR Health | Bradenton, Florida, United States | Recruiting |
+ 18 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05758545